{
    "Case ID": "018357",
    "Different Crime": [
        {
            "Crime Name": "unknown",
            "Crime Type": "others",
            "infringement_analysis": [
                "formulation of capsules from bulk nizatidine"
            ],
            "specific_rule_applied": [
                "s. 6 of the Regulations"
            ],
            "application_details": [
                "Apotex planned to make capsules from bulk nizatidine purchased from Novopharm under its licence"
            ],
            "decision_reasoning": [
                "Unlicensed third-party purchasers do not inherit licensed rights solely by purchasing bulk material"
            ],
            "result_of_case": [
                "The court prohibited the Minister from issuing a notice of compliance to Apotex until patents expire"
            ],
            "cause_of_action": [
                "Eli Lilly sought to prevent Apotex from marketing nizatidine, alleging infringement due to Apotex's unlicensed activities"
            ]
        }
    ]
}